NCT04161521

Brief Summary

Evaluation of maternal morbidity and mortality of our novel surgical procedure for conservative management of placenta accreta in our tertiary referral institute.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 5, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 13, 2019

Completed
Last Updated

November 13, 2019

Status Verified

November 1, 2019

Enrollment Period

1 year

First QC Date

November 5, 2019

Last Update Submit

November 9, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Outcome variables: Need for conversion to hysterectomy.

    control of bleeding and need for removal of uterus.

    30- 90 minutes

  • Blood Loss.

    Amount of blood loss ,Number of packed red blood cells and blood products transfusion.

    During operation and 24 hours postpartum.

Secondary Outcomes (1)

  • Intraoperative complications

    During operation and postpartum period.

Study Arms (1)

Placenta Accreta patients

OTHER

of 60 pregnant female diagnosed as placenta previa accreta recuirted from Obstetrics and Gynecology Department , Menoufia University Hospital.

Procedure: Novel Technique of Placenta Accreta in Menoufia University Hospital

Interventions

* Classical CS to decrease haemorrhage from placental bed. * Delievery of the fetus. * At the delivery 10 UI of oxytocin IV will be injected. * The placenta is not attempted to be delievered. * Opening of the broad ligament via round ligament division and ligation. * Gentle dissection of the urinary bladder from lateral to medial. * Bilateral uterine artery clamping at low level below the placental bed . * Gentle attempt to deliver The placenta. * If the placenta is delievered we will do bilateral uterine artery ligation at multiple levels and multiple square compression sutures(if needed) for proper hemeostasis at the placental bed. Then closure of uterine incision. * If the placenta is not delievered we will do segmental ressection of lower uterine segment including the placenta . * Intraperitoneal drain insertion.

Placenta Accreta patients

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 20 - 40 years old. 2- Gestational age between 28 - 38 weeks. 3- Any patient diagnosed as placenta previa with ultrasound criteria of accretion.
  • Criteria of accretion by Colour Doppler ultrasound include: (Berkley et al., 2013).
  • The presence of irregular shaped placental lacunae within the placenta.
  • Thinning of myometrium overlying the placenta.
  • Absence of retroplacental 'non-lucent line'.
  • Protrusion of the placenta into the bladder.
  • Increased vascularity of the uterine serosa-bladder interface.
  • Turbulent blood flow through the lacunae on Doppler ultrasonography.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Menoufia University hospital

Shibīn al Kawm, Menoufia, 11111, Egypt

Location

Hamed Elsayed Ellakwa

Shibīn al Kawm, 11111, Egypt

Location

Related Publications (1)

  • Elkhouly NI, Solyman AE, Anter ME, Sanad ZF, El Ghazaly AN, Ellakwa HE. A new conservative surgical approach for placenta accreta spectrum in a low-resource setting. J Matern Fetal Neonatal Med. 2022 Aug;35(16):3076-3082. doi: 10.1080/14767058.2020.1808616. Epub 2020 Aug 25.

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Study Officials

  • Hamed E Ellakwa

    Menoufia

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Hamed Ellakwa

Study Record Dates

First Submitted

November 5, 2019

First Posted

November 13, 2019

Study Start

November 1, 2018

Primary Completion

November 1, 2019

Study Completion

November 1, 2019

Last Updated

November 13, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations